129 related articles for article (PubMed ID: 36522164)
1. [Comparative Harm/Benefit Analysis of Various Psychotropic Substances from the Perspective of German Drug Users and Addiction Medicine Experts - A Contribution to Psychoeducation of Substance-Addicted Individuals and Restriction/Legalization Debates].
Kanti AK; Specka M; Scherbaum N; Bonnet U
Fortschr Neurol Psychiatr; 2022 Dec; ():. PubMed ID: 36522164
[TBL] [Abstract][Full Text] [Related]
2. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
Bonnet U; Specka M; Kanti AK; Scherbaum N
Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
[TBL] [Abstract][Full Text] [Related]
3. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
[TBL] [Abstract][Full Text] [Related]
4. Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.
Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Grigoleit T; Hermle L; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Luckhaus C; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck GA; Wodarz N; McAnally H; Scherbaum N
Front Psychiatry; 2020; 11():592199. PubMed ID: 33192740
[No Abstract] [Full Text] [Related]
5. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
[TBL] [Abstract][Full Text] [Related]
6. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
7. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.
Shapira B; Rosca P; Berkovitz R; Gorjaltsan I; Neumark Y
PeerJ; 2020; 8():e9461. PubMed ID: 32742781
[TBL] [Abstract][Full Text] [Related]
8. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
9. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
[TBL] [Abstract][Full Text] [Related]
10. Perceived harmfulness of substance use: a pilot study.
Sarkar S; Balachander S; Basu D
Indian J Community Med; 2014 Jan; 39(1):26-9. PubMed ID: 24696536
[TBL] [Abstract][Full Text] [Related]
11. [Substance use, affective problems and personality traits: test of two association models].
Chakroun N; Doron J; Swendsen J
Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
[TBL] [Abstract][Full Text] [Related]
12. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
[TBL] [Abstract][Full Text] [Related]
14. Quantitative damage-benefit evaluation of drug effects: major discrepancies between the general population, users and experts.
Reynaud M; Luquiens A; Aubin HJ; Talon C; Bourgain C
J Psychopharmacol; 2013 Jul; 27(7):590-9. PubMed ID: 23676197
[TBL] [Abstract][Full Text] [Related]
15. Licit and illicit substance use patterns among university students in Germany using cluster analysis.
Schilling L; Zeeb H; Pischke C; Helmer S; Schmidt-Pokrzywniak A; Reintjes R; Walter U; Girbig M; Krämer A; Icks A; Schneider S
Subst Abuse Treat Prev Policy; 2017 Oct; 12(1):44. PubMed ID: 29058635
[TBL] [Abstract][Full Text] [Related]
16. Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.
Revol B; Willeman T; Manceau M; Dumestre-Toulet V; Gaulier JM; Fouilhé Sam-Laï N; Eysseric-Guérin H;
JAMA Netw Open; 2023 Aug; 6(8):e2331398. PubMed ID: 37647066
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland.
Taylor M; Mackay K; Murphy J; McIntosh A; McIntosh C; Anderson S; Welch K
BMJ Open; 2012; 2(4):. PubMed ID: 22833648
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of psychotic symptoms in substance users: a comparison across substances.
Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of changes in illicit drugs, alcohol, and nicotine consumption during Ramadan via wastewater analysis.
Guzel EY
Environ Sci Pollut Res Int; 2022 Dec; 29(59):89245-89254. PubMed ID: 35851933
[TBL] [Abstract][Full Text] [Related]
20. Assessing the impact of a major electronic music festival on the consumption patterns of illicit and licit psychoactive substances in a Mediterranean city using wastewater analysis.
Senta I; Krizman-Matasic I; Kostanjevecki P; Gonzalez-Mariño I; Rodil R; Quintana JB; Mikac I; Terzic S; Ahel M
Sci Total Environ; 2023 Sep; 892():164547. PubMed ID: 37270014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
